ftInvstr
KOPRAN · Healthcare ₹259.55 -1.39% Mkt Cap ₹1258 Cr fair
← Search another stock

KOPRAN

Healthcare Drug Manufacturers - General
★ Watchlist ⧉ Add to bucket
₹259.55
-1.39% today · 30d +4.03%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for KOPRAN. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹211 Cr
+79.17% YoY
NET PROFIT
₹4 Cr
OPM
7.57%
+12.02pp YoY
EPS
₹0.91
PE 32.42
Intrinsic value · DCF ₹268.11 · Margin of safety +3.3% (fair) · FCF yield 0.66%
◇ Sector Position
PEERPEROCE %
KOPRAN32.427.0
GLAXO40.0557.97
RUBICON90.2127.36
PFIZER20.9324.29
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
63
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation FAIR 40
Growth MUTED 39
Profitability AVERAGE 30
Technicals STRONG 80
Risk LOW 90
Key Stats
TTM PE
32.42
P/B
2.4
52W HIGH
₹295.83
OFF HIGH
-12.26%
DIV YIELD
1.15%
MKT CAP
₹1258 Cr
◉ Active Signals
MACDBullish0.327
RSI(14)Neutral51.26
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold KOPRAN and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.